Metronomic Chemotherapy PDF Download

Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Metronomic Chemotherapy PDF full book. Access full book title Metronomic Chemotherapy.

Metronomic Chemotherapy

Metronomic Chemotherapy
Author: Guido Bocci
Publisher: Springer
Total Pages: 302
Release: 2014-09-04
Genre: Medical
ISBN: 3662436043

Download Metronomic Chemotherapy Book in PDF, ePub and Kindle

This book analyzes all aspects of metronomic chemotherapy, a new approach involving low-dose, long-term, and frequently administered therapy that has preclinical and clinical activity in various tumors. After an opening section on the pharmacological bases of metronomic chemotherapy, including its antiangiogenic effects and impact on immunity, preclinical studies on various classes of drug are discussed. Clinical applications of metronomic chemotherapy in a wide variety of tumors are then addressed in detail, with description of the results of all published studies. The clinical pharmacology of metronomic chemotherapy is also considered in depth, encompassing pharmacokinetics, pharmacogenetics, pharmacoeconomics, and adverse drug reactions. The book closes by describing the role of this therapy in the veterinarian clinic.


Metronomic Chemotherapy

Metronomic Chemotherapy
Author: Guido Bocci
Publisher: Springer
Total Pages: 0
Release: 2016-09-22
Genre: Medical
ISBN: 9783662513194

Download Metronomic Chemotherapy Book in PDF, ePub and Kindle

This book analyzes all aspects of metronomic chemotherapy, a new approach involving low-dose, long-term, and frequently administered therapy that has preclinical and clinical activity in various tumors. After an opening section on the pharmacological bases of metronomic chemotherapy, including its antiangiogenic effects and impact on immunity, preclinical studies on various classes of drug are discussed. Clinical applications of metronomic chemotherapy in a wide variety of tumors are then addressed in detail, with description of the results of all published studies. The clinical pharmacology of metronomic chemotherapy is also considered in depth, encompassing pharmacokinetics, pharmacogenetics, pharmacoeconomics, and adverse drug reactions. The book closes by describing the role of this therapy in the veterinarian clinic.


Novel Approaches in Metronomic Chemotherapy for Breast Cancer Treatment

Novel Approaches in Metronomic Chemotherapy for Breast Cancer Treatment
Author: Manzoor Ahmad Mir
Publisher: CRC Press
Total Pages: 255
Release: 2024-05-28
Genre: Medical
ISBN: 1040013716

Download Novel Approaches in Metronomic Chemotherapy for Breast Cancer Treatment Book in PDF, ePub and Kindle

This book provides the latest research and developments in the field of metronomic chemotherapy for breast cancer. It presents the principles and mechanisms of metronomic chemotherapy, preclinical and clinical studies, and the latest developments in drug delivery systems and nanoformulations. The clinical pharmacology of metronomic chemotherapy, including pharmacokinetics, pharmacogenetics, pharmacoeconomics, and adverse drug reactions, are also examined. Key Features: Introduces metronomics therapy in the neoadjuvant and adjuvant treatment of breast cancer Explores the potential of metronomics in terms of personalized chemotherapy Present pharmacological bases of metronomic chemotherapy Covers the latest developments in drug delivery systems, nanotechnology, and nanoformulations Discusses antiangiogenic effects and the impact of metronomics on immunity This book is useful for students, researchers, oncologists, pharmacologists, and healthcare experts interested in understanding the clinical potential of metronomic chemotherapy in breast cancer.


Metronomic Chemotherapy

Metronomic Chemotherapy
Author:
Publisher:
Total Pages: 7
Release: 2014
Genre:
ISBN:

Download Metronomic Chemotherapy Book in PDF, ePub and Kindle

The administration of chemotherapy at reduced doses given at regular, frequent time intervals, termed 'metronomic' chemotherapy, presents an alternative to standard maximal tolerated dose (MTD) chemotherapy. The primary target of metronomic chemotherapy was originally identified as endothelial cells supporting the tumor vasculature, and not the tumor cells themselves, consistent with the emerging concept of cancer as a systemic disease involving both tumor cells and their microenvironment. While anti-angiogenesis is an important mechanism of action of metronomic chemotherapy, other mechanisms, including activation of anti-tumor immunity and a decrease in acquired therapeutic resistance, have also been identified. In this paper, we present evidence supporting a mechanistic explanation for the improved activity of cancer chemotherapy when administered on a metronomic, rather than an MTD schedule and discuss the implications of these findings for further translation into the clinic.


Clinical Applications of Metronomic Chemotherapy

Clinical Applications of Metronomic Chemotherapy
Author: Guido Bocci
Publisher: Mdpi AG
Total Pages: 0
Release: 2023-12-15
Genre: Medical
ISBN: 9783036592800

Download Clinical Applications of Metronomic Chemotherapy Book in PDF, ePub and Kindle

Metronomic chemotherapy is now, finally, in clinical use. After 20 years of preclinical development and clinical trials, the emerging data will be of paramount importance in allowing us to assess the impact of metronomic chemotherapy on different tumor types. Indeed, it is likely that the next decade will see a major reassessment of the possible applications of metronomic chemotherapy, both alone and in combination with new therapeutic approaches such as immunotherapies, for the management of cancer. Moreover, the results of clinical trials will likely profoundly affect the direction of the laboratory efforts that are going on in parallel and aiming to improve the personalization of this therapeutic strategy. This Special Issue is our attempt to cover the past and present clinical results that have brought us to this pivotal moment and will form the basis of future clinical developments. Scientists and clinicians caring for cancer patients are well aware of the challenges in dealing with this particular therapeutic approach; one such challenge is obtaining improvements in patient survival without significant toxicity. This edition includes clinical research on chemotherapy and ongoing controversies related to metronomic chemotherapy.


CD4+CD25+ Regulatory T Cells: Origin, Function and Therapeutic Potential

CD4+CD25+ Regulatory T Cells: Origin, Function and Therapeutic Potential
Author: B. Kyewski
Publisher: Springer Science & Business Media
Total Pages: 331
Release: 2006-01-09
Genre: Medical
ISBN: 3540277021

Download CD4+CD25+ Regulatory T Cells: Origin, Function and Therapeutic Potential Book in PDF, ePub and Kindle

The vertebrate immune system defends the organism against invading pathogens while at the same time being self-tolerant to the body’s own constituents thus preserving its integrity. Multiple mechanisms work in concert to ensure self-tolerance. Apart from purging the T cell repertoire from auto-reactive T cells via negative selection in the thymus dominant tolerance exerted by regulatory T cells plays a major role in tolerance imposition and maintenance. Among the various regulatory/suppressive cells hitherto described, CD4+CD25+ regulatory T cells (Treg) and interleukin-10 producing T regulatory 1 (Tr1) cells have been studied in most detail and are the subject of most articles in this issue. Treg, also called "natural" regulatory T cells, will be traced from their intra-thymic origin to the site of their action in peripheral lymphoid organs and tissues. The repertoire of Treg is clearly biased towards recognition of self-antigens, thereby potentially preventing autoimmune diseases such as gastritis and oophoritis. Regulatory T cells, however also control infections, allergies and tolerance to transplanted tissues and this requires their induction in the periphery under conditions which are not yet fully understood. The concept of dominant tolerance, by far not novel, will offer new insights and hopefully tools for the successful treatment of autoimmune diseases, improved cancer immunotherapy and transplant survival. The fulfillment of these high expectations will, however, require their unambiguous identification and a better understanding of their mode of action.


Diagnosis and Management of Ovarian Disorders

Diagnosis and Management of Ovarian Disorders
Author: Albert Altchek
Publisher: Elsevier
Total Pages: 595
Release: 2003-09-04
Genre: Medical
ISBN: 008049451X

Download Diagnosis and Management of Ovarian Disorders Book in PDF, ePub and Kindle

This updated second edition of Diagnosis and Management of Ovarian Disorders provides thorough, yet succinct insight into the ever-changing realm of ovarian disorders. It presents a novel multidisciplinary approach to the subject as described by clinicians, surgeons, pathologists, basic scientists and related medical researchers. Topics covered include reproductive technology, early diagnosis of ovarian cancer, and management of menopause among others. The breadth of information provided by this book will appeal to clinicians and researchers involved in the study and treatment of ovarian disorders. KEY FEATURES* Includes updated information on early diagnosis of ovarian cancer* Reviews new diagnostic techniques for ovarian disorders* Discusses latest information on reproductive technology* Presents translational treatment linking laboratory research with clinical medicine


The Dog Cancer Survival Guide

The Dog Cancer Survival Guide
Author: Demian Dressler
Publisher: Maui Media
Total Pages: 0
Release: 2011
Genre: Medical
ISBN: 9780975263150

Download The Dog Cancer Survival Guide Book in PDF, ePub and Kindle

If your dog has cancer, you need this book. No matter what you've heard, there are always steps you can take to help your dog fight (and even beat) cancer. This scientifically researched guide is your complete reference for practical, evidence-based strategies that can optimize the life quality and longevity for your dog. No matter what diagnosis or stage of cancer your dog has, this book is packed with precious advice that can help now. Discover the Full Spectrum approach to dog cancer care: Everything you need to know about conventional western veterinary treatments (surgery, chemotherapy and radiation) including how to reduce their side effects. The most effective non-conventional options, including botanical nutraceuticals, supplements, nutrition, and mind-body medicine. How to analyze the options and develop a specific plan for your own dog based on your dog's type of cancer, your dog's age, your financial and time budget, your personality, and many other personal factors. Imagine looking back at this time in your life, five years from now, and having not a single regret. You can help your dog fight cancer and you can honor your dog's life by living each moment to the fullest, starting now. This book can help you as it has helped thousands of other dog lovers. The Authors Dr. Demian Dressler, DVM practices in Hawaii and is internationally recognized as "the dog cancer vet" and blogs at DogCancerBlog.com. Dr. Susan Ettinger, DVM is a veterinary oncologist and a diplomate of the American College of Internal Medicine who practices in New York. Praise from Veterinarians, Authors & Book Reviewers "The future is upon us and this ground-breaking book is a vital cornerstone. In dealing with cancer, our worst illness, this Survival Guide is educational, logical, expansive, embracing, honest and so needed." Dr. Marty Goldstein, DVM Holistic veterinarian and Host, Ask Martha Stewart's Vet on Sirius Radio "The message of this book jumps off the written page and into the heart of every reader, and will become the at home bible for cancer care of dogs. The authors have given you a sensible and systematic approach that practicing veterinarians will cherish. I found the book inspiring and, clearly, it will become part of my daily approach to cancer therapy for my own patients." Dr. Robert B. Cohen, VMD Bay Street Animal Hospital, New York "I wish that I had had The Dog Cancer Survival Guide when my dearly beloved Flat-coated Retriever, Odin, contracted cancer. It would have provided me alternative courses of action, as well as some well needed "reality checks" which were not available from conversations with my veterinarian. It should be on every dog owner's book shelf--just in case..." Dr. Stanley Coren, PhD, FRSC author of many books, including Born to Bark "A comprehensive guide that distills both alternative and allopathic cancer treatments in dogs...With the overwhelming amount of conflicting information about cancer prevention and treatment, this book provides a pet owner with an easy to follow approach to one of the most serious diseases in animals." Dr. Barbara Royal, DVM The Royal Treatment Veterinary Center, Oprah Winfrey's Chicago veterinarian "Picking up The Dog Cancer Survival Guide is anything but a downer: it's an 'empowerer.' It will make you feel like the best medical advocate for your dog. It covers canine cancer topics to an unprecedented depth and breadth from emotional coping strategies to prevention-in plain English.Read this book, and you will understand cancer stages, treatment options, and types, and much more. If you have just had the dreaded news, pick up a copy and it will guide the decisions your dog trusts you to make." Laure-Anne Visel Dog behavior specialist and technical dog writer, CanisBonus.com


Low Dose Metronomic Chemotherapy as an Efficient Treatment Option in Metastatic Breast Cancer - Results of an Exploratory Case-control Study

Low Dose Metronomic Chemotherapy as an Efficient Treatment Option in Metastatic Breast Cancer - Results of an Exploratory Case-control Study
Author: Slavomir Krajnak
Publisher:
Total Pages:
Release: 2017
Genre:
ISBN:

Download Low Dose Metronomic Chemotherapy as an Efficient Treatment Option in Metastatic Breast Cancer - Results of an Exploratory Case-control Study Book in PDF, ePub and Kindle

Background:There is a growing importance of low-dose metronomic chemotherapy (LDMC) in metastatic breast cancer (MBC). In this retrospective case-control-analysis we compared the efficacy of LDMC and conventional chemotherapy in MBC.Methods:Each LDMC patient receiving oral cyclophosphamide (CTX) (50 mg daily) and methotrexate (MTX) (2.5 mg every other day) was matched with two patients who received conventional chemotherapy. Age, number of chemotherapy lines and metastatic lesions as well as hormone receptor (HR) status were considered as matching criteria. Primary endpoint was disease control rate greater than 24 weeks (DCR). Secondary endpoints were DCR in subgroups (age at begin of therapy, number of chemotherapy lines, number of different metastatic lesions and HR status), progression-free survival (PFS) and duration of response (DoR).Results:A total of 40 cases and 80 controls entered the study. 30% patients with LDMC and 23% patients with conventional chemotherapy showed DCR (p=0.380). Among younger patients DCR was 40% in LDMC vs. 25% in the control group (p=0.249). In addition, DCR was achieved in 33% vs. 26% patients with u2264 2 chemotherapy lines (p=0.568) and in 36% vs. 18% patients with u2264 2 different metastatic lesions (p=0.096), respectively. In the triple negative group 30% LDMC vs. 5% control patients showed DCR (p=0.095). The median PFS was 12.5 weeks in both groups (p=0.218). The median DoR was 31 weeks in LDMC and 21 weeks in the control group (p=0.383).Conclusion:In this retrospective case-control study we demonstrated a similar efficacy of LDMC compared to conventional chemotherapy in the treatment of MBC. Moreover, no significant differences were found in the subgroups studied. Therefore, the concept of LDMC may also be a treatment option in both younger and non-heavily pre-treated MBC patients who do not need rapid remission.


Clinically Relevant Resistance in Cancer Chemotherapy

Clinically Relevant Resistance in Cancer Chemotherapy
Author: Borje Andersson
Publisher: Springer Science & Business Media
Total Pages: 391
Release: 2012-12-06
Genre: Medical
ISBN: 1461511739

Download Clinically Relevant Resistance in Cancer Chemotherapy Book in PDF, ePub and Kindle

Over the last several decades, the introduction of new chemotherapeutic drugs and drug combinations has resulted in increased long term remission rates in several important tumor types. These include childhood leukemia, adult leukemias and lymphomas, as well as testicular and trophoblastic tumors. The addition of high-dose chemotherapy with growth factor and hemopoietic stem cell support has increased clinical remission rates even further. For the majority of patients with some of the more common malignancies, however, palliation (rather than cure) is still the most realistic goal of chemotherapy for metastatic disease. The failure of chemotherapy to cure metastatic cancer is commonly referred to among clinicians as "drug resistance". This phenomenon can, however, often be viewed as the survival of malignant cells that resulted from a failure to deliver an effective drug dose to the (cellular) target because of anyone of or combination of a multitude of individual factors. Clinically, this treatment failure is often viewed as the rapid occurrence of resistance at the single cell level. However, in experimental systems, stable drug resistance is usually relatively slow to emerge.